img

Global Genome Editing and Genome Engineering Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Genome Editing and Genome Engineering Market Research Report 2024

Genome editing technology refers to the ability of human to "edit" the target gene, such as the deletion and addition of specific DNA fragments.
According to MRAResearch’s new survey, global Genome Editing and Genome Engineering market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Genome Editing and Genome Engineering market research.
Key companies engaged in the Genome Editing and Genome Engineering industry include Thermo Fisher Scientific, Merck, Horizon Discovery, Genscript, Sangamo Biosciences, Integrated DNA Technologies, Lonza, New England Biolabs and Origene Technologies, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Genome Editing and Genome Engineering were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Genome Editing and Genome Engineering market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Genome Editing and Genome Engineering market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Thermo Fisher Scientific
Merck
Horizon Discovery
Genscript
Sangamo Biosciences
Integrated DNA Technologies
Lonza
New England Biolabs
Origene Technologies
Transposagen Biopharmaceuticals
Editas Medicine
Crispr Therapeutics
Tecan Life Sciences
Segment by Type
CRISPR
TALEN
ZFN

Segment by Application


Cell Line Engineering
Animal Genetic Engineering
Plant Genetic Engineering
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Genome Editing and Genome Engineering report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genome Editing and Genome Engineering Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 CRISPR
1.2.3 TALEN
1.2.4 ZFN
1.3 Market by Application
1.3.1 Global Genome Editing and Genome Engineering Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Cell Line Engineering
1.3.3 Animal Genetic Engineering
1.3.4 Plant Genetic Engineering
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Genome Editing and Genome Engineering Market Perspective (2018-2033)
2.2 Genome Editing and Genome Engineering Growth Trends by Region
2.2.1 Global Genome Editing and Genome Engineering Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Genome Editing and Genome Engineering Historic Market Size by Region (2018-2023)
2.2.3 Genome Editing and Genome Engineering Forecasted Market Size by Region (2024-2033)
2.3 Genome Editing and Genome Engineering Market Dynamics
2.3.1 Genome Editing and Genome Engineering Industry Trends
2.3.2 Genome Editing and Genome Engineering Market Drivers
2.3.3 Genome Editing and Genome Engineering Market Challenges
2.3.4 Genome Editing and Genome Engineering Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Genome Editing and Genome Engineering Players by Revenue
3.1.1 Global Top Genome Editing and Genome Engineering Players by Revenue (2018-2023)
3.1.2 Global Genome Editing and Genome Engineering Revenue Market Share by Players (2018-2023)
3.2 Global Genome Editing and Genome Engineering Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Genome Editing and Genome Engineering Revenue
3.4 Global Genome Editing and Genome Engineering Market Concentration Ratio
3.4.1 Global Genome Editing and Genome Engineering Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genome Editing and Genome Engineering Revenue in 2022
3.5 Genome Editing and Genome Engineering Key Players Head office and Area Served
3.6 Key Players Genome Editing and Genome Engineering Product Solution and Service
3.7 Date of Enter into Genome Editing and Genome Engineering Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Genome Editing and Genome Engineering Breakdown Data by Type
4.1 Global Genome Editing and Genome Engineering Historic Market Size by Type (2018-2023)
4.2 Global Genome Editing and Genome Engineering Forecasted Market Size by Type (2024-2033)
5 Genome Editing and Genome Engineering Breakdown Data by Application
5.1 Global Genome Editing and Genome Engineering Historic Market Size by Application (2018-2023)
5.2 Global Genome Editing and Genome Engineering Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Genome Editing and Genome Engineering Market Size (2018-2033)
6.2 North America Genome Editing and Genome Engineering Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Genome Editing and Genome Engineering Market Size by Country (2018-2023)
6.4 North America Genome Editing and Genome Engineering Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Genome Editing and Genome Engineering Market Size (2018-2033)
7.2 Europe Genome Editing and Genome Engineering Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Genome Editing and Genome Engineering Market Size by Country (2018-2023)
7.4 Europe Genome Editing and Genome Engineering Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Genome Editing and Genome Engineering Market Size (2018-2033)
8.2 Asia-Pacific Genome Editing and Genome Engineering Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Genome Editing and Genome Engineering Market Size by Region (2018-2023)
8.4 Asia-Pacific Genome Editing and Genome Engineering Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Genome Editing and Genome Engineering Market Size (2018-2033)
9.2 Latin America Genome Editing and Genome Engineering Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Genome Editing and Genome Engineering Market Size by Country (2018-2023)
9.4 Latin America Genome Editing and Genome Engineering Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Genome Editing and Genome Engineering Market Size (2018-2033)
10.2 Middle East & Africa Genome Editing and Genome Engineering Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Genome Editing and Genome Engineering Market Size by Country (2018-2023)
10.4 Middle East & Africa Genome Editing and Genome Engineering Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Genome Editing and Genome Engineering Introduction
11.1.4 Thermo Fisher Scientific Revenue in Genome Editing and Genome Engineering Business (2018-2023)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Genome Editing and Genome Engineering Introduction
11.2.4 Merck Revenue in Genome Editing and Genome Engineering Business (2018-2023)
11.2.5 Merck Recent Development
11.3 Horizon Discovery
11.3.1 Horizon Discovery Company Detail
11.3.2 Horizon Discovery Business Overview
11.3.3 Horizon Discovery Genome Editing and Genome Engineering Introduction
11.3.4 Horizon Discovery Revenue in Genome Editing and Genome Engineering Business (2018-2023)
11.3.5 Horizon Discovery Recent Development
11.4 Genscript
11.4.1 Genscript Company Detail
11.4.2 Genscript Business Overview
11.4.3 Genscript Genome Editing and Genome Engineering Introduction
11.4.4 Genscript Revenue in Genome Editing and Genome Engineering Business (2018-2023)
11.4.5 Genscript Recent Development
11.5 Sangamo Biosciences
11.5.1 Sangamo Biosciences Company Detail
11.5.2 Sangamo Biosciences Business Overview
11.5.3 Sangamo Biosciences Genome Editing and Genome Engineering Introduction
11.5.4 Sangamo Biosciences Revenue in Genome Editing and Genome Engineering Business (2018-2023)
11.5.5 Sangamo Biosciences Recent Development
11.6 Integrated DNA Technologies
11.6.1 Integrated DNA Technologies Company Detail
11.6.2 Integrated DNA Technologies Business Overview
11.6.3 Integrated DNA Technologies Genome Editing and Genome Engineering Introduction
11.6.4 Integrated DNA Technologies Revenue in Genome Editing and Genome Engineering Business (2018-2023)
11.6.5 Integrated DNA Technologies Recent Development
11.7 Lonza
11.7.1 Lonza Company Detail
11.7.2 Lonza Business Overview
11.7.3 Lonza Genome Editing and Genome Engineering Introduction
11.7.4 Lonza Revenue in Genome Editing and Genome Engineering Business (2018-2023)
11.7.5 Lonza Recent Development
11.8 New England Biolabs
11.8.1 New England Biolabs Company Detail
11.8.2 New England Biolabs Business Overview
11.8.3 New England Biolabs Genome Editing and Genome Engineering Introduction
11.8.4 New England Biolabs Revenue in Genome Editing and Genome Engineering Business (2018-2023)
11.8.5 New England Biolabs Recent Development
11.9 Origene Technologies
11.9.1 Origene Technologies Company Detail
11.9.2 Origene Technologies Business Overview
11.9.3 Origene Technologies Genome Editing and Genome Engineering Introduction
11.9.4 Origene Technologies Revenue in Genome Editing and Genome Engineering Business (2018-2023)
11.9.5 Origene Technologies Recent Development
11.10 Transposagen Biopharmaceuticals
11.10.1 Transposagen Biopharmaceuticals Company Detail
11.10.2 Transposagen Biopharmaceuticals Business Overview
11.10.3 Transposagen Biopharmaceuticals Genome Editing and Genome Engineering Introduction
11.10.4 Transposagen Biopharmaceuticals Revenue in Genome Editing and Genome Engineering Business (2018-2023)
11.10.5 Transposagen Biopharmaceuticals Recent Development
11.11 Editas Medicine
11.11.1 Editas Medicine Company Detail
11.11.2 Editas Medicine Business Overview
11.11.3 Editas Medicine Genome Editing and Genome Engineering Introduction
11.11.4 Editas Medicine Revenue in Genome Editing and Genome Engineering Business (2018-2023)
11.11.5 Editas Medicine Recent Development
11.12 Crispr Therapeutics
11.12.1 Crispr Therapeutics Company Detail
11.12.2 Crispr Therapeutics Business Overview
11.12.3 Crispr Therapeutics Genome Editing and Genome Engineering Introduction
11.12.4 Crispr Therapeutics Revenue in Genome Editing and Genome Engineering Business (2018-2023)
11.12.5 Crispr Therapeutics Recent Development
11.13 Tecan Life Sciences
11.13.1 Tecan Life Sciences Company Detail
11.13.2 Tecan Life Sciences Business Overview
11.13.3 Tecan Life Sciences Genome Editing and Genome Engineering Introduction
11.13.4 Tecan Life Sciences Revenue in Genome Editing and Genome Engineering Business (2018-2023)
11.13.5 Tecan Life Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Genome Editing and Genome Engineering Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of CRISPR
Table 3. Key Players of TALEN
Table 4. Key Players of ZFN
Table 5. Global Genome Editing and Genome Engineering Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Genome Editing and Genome Engineering Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Genome Editing and Genome Engineering Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Genome Editing and Genome Engineering Market Share by Region (2018-2023)
Table 9. Global Genome Editing and Genome Engineering Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Genome Editing and Genome Engineering Market Share by Region (2024-2033)
Table 11. Genome Editing and Genome Engineering Market Trends
Table 12. Genome Editing and Genome Engineering Market Drivers
Table 13. Genome Editing and Genome Engineering Market Challenges
Table 14. Genome Editing and Genome Engineering Market Restraints
Table 15. Global Genome Editing and Genome Engineering Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Genome Editing and Genome Engineering Market Share by Players (2018-2023)
Table 17. Global Top Genome Editing and Genome Engineering Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genome Editing and Genome Engineering as of 2022)
Table 18. Ranking of Global Top Genome Editing and Genome Engineering Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Genome Editing and Genome Engineering Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Genome Editing and Genome Engineering Product Solution and Service
Table 22. Date of Enter into Genome Editing and Genome Engineering Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Genome Editing and Genome Engineering Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Genome Editing and Genome Engineering Revenue Market Share by Type (2018-2023)
Table 26. Global Genome Editing and Genome Engineering Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Genome Editing and Genome Engineering Revenue Market Share by Type (2024-2033)
Table 28. Global Genome Editing and Genome Engineering Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Genome Editing and Genome Engineering Revenue Market Share by Application (2018-2023)
Table 30. Global Genome Editing and Genome Engineering Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Genome Editing and Genome Engineering Revenue Market Share by Application (2024-2033)
Table 32. North America Genome Editing and Genome Engineering Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Genome Editing and Genome Engineering Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Genome Editing and Genome Engineering Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Genome Editing and Genome Engineering Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Genome Editing and Genome Engineering Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Genome Editing and Genome Engineering Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Genome Editing and Genome Engineering Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Genome Editing and Genome Engineering Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Genome Editing and Genome Engineering Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Genome Editing and Genome Engineering Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Genome Editing and Genome Engineering Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Genome Editing and Genome Engineering Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Genome Editing and Genome Engineering Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Genome Editing and Genome Engineering Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Genome Editing and Genome Engineering Market Size by Country (2024-2033) & (US$ Million)
Table 47. Thermo Fisher Scientific Company Detail
Table 48. Thermo Fisher Scientific Business Overview
Table 49. Thermo Fisher Scientific Genome Editing and Genome Engineering Product
Table 50. Thermo Fisher Scientific Revenue in Genome Editing and Genome Engineering Business (2018-2023) & (US$ Million)
Table 51. Thermo Fisher Scientific Recent Development
Table 52. Merck Company Detail
Table 53. Merck Business Overview
Table 54. Merck Genome Editing and Genome Engineering Product
Table 55. Merck Revenue in Genome Editing and Genome Engineering Business (2018-2023) & (US$ Million)
Table 56. Merck Recent Development
Table 57. Horizon Discovery Company Detail
Table 58. Horizon Discovery Business Overview
Table 59. Horizon Discovery Genome Editing and Genome Engineering Product
Table 60. Horizon Discovery Revenue in Genome Editing and Genome Engineering Business (2018-2023) & (US$ Million)
Table 61. Horizon Discovery Recent Development
Table 62. Genscript Company Detail
Table 63. Genscript Business Overview
Table 64. Genscript Genome Editing and Genome Engineering Product
Table 65. Genscript Revenue in Genome Editing and Genome Engineering Business (2018-2023) & (US$ Million)
Table 66. Genscript Recent Development
Table 67. Sangamo Biosciences Company Detail
Table 68. Sangamo Biosciences Business Overview
Table 69. Sangamo Biosciences Genome Editing and Genome Engineering Product
Table 70. Sangamo Biosciences Revenue in Genome Editing and Genome Engineering Business (2018-2023) & (US$ Million)
Table 71. Sangamo Biosciences Recent Development
Table 72. Integrated DNA Technologies Company Detail
Table 73. Integrated DNA Technologies Business Overview
Table 74. Integrated DNA Technologies Genome Editing and Genome Engineering Product
Table 75. Integrated DNA Technologies Revenue in Genome Editing and Genome Engineering Business (2018-2023) & (US$ Million)
Table 76. Integrated DNA Technologies Recent Development
Table 77. Lonza Company Detail
Table 78. Lonza Business Overview
Table 79. Lonza Genome Editing and Genome Engineering Product
Table 80. Lonza Revenue in Genome Editing and Genome Engineering Business (2018-2023) & (US$ Million)
Table 81. Lonza Recent Development
Table 82. New England Biolabs Company Detail
Table 83. New England Biolabs Business Overview
Table 84. New England Biolabs Genome Editing and Genome Engineering Product
Table 85. New England Biolabs Revenue in Genome Editing and Genome Engineering Business (2018-2023) & (US$ Million)
Table 86. New England Biolabs Recent Development
Table 87. Origene Technologies Company Detail
Table 88. Origene Technologies Business Overview
Table 89. Origene Technologies Genome Editing and Genome Engineering Product
Table 90. Origene Technologies Revenue in Genome Editing and Genome Engineering Business (2018-2023) & (US$ Million)
Table 91. Origene Technologies Recent Development
Table 92. Transposagen Biopharmaceuticals Company Detail
Table 93. Transposagen Biopharmaceuticals Business Overview
Table 94. Transposagen Biopharmaceuticals Genome Editing and Genome Engineering Product
Table 95. Transposagen Biopharmaceuticals Revenue in Genome Editing and Genome Engineering Business (2018-2023) & (US$ Million)
Table 96. Transposagen Biopharmaceuticals Recent Development
Table 97. Editas Medicine Company Detail
Table 98. Editas Medicine Business Overview
Table 99. Editas Medicine Genome Editing and Genome Engineering Product
Table 100. Editas Medicine Revenue in Genome Editing and Genome Engineering Business (2018-2023) & (US$ Million)
Table 101. Editas Medicine Recent Development
Table 102. Crispr Therapeutics Company Detail
Table 103. Crispr Therapeutics Business Overview
Table 104. Crispr Therapeutics Genome Editing and Genome Engineering Product
Table 105. Crispr Therapeutics Revenue in Genome Editing and Genome Engineering Business (2018-2023) & (US$ Million)
Table 106. Crispr Therapeutics Recent Development
Table 107. Tecan Life Sciences Company Detail
Table 108. Tecan Life Sciences Business Overview
Table 109. Tecan Life Sciences Genome Editing and Genome Engineering Product
Table 110. Tecan Life Sciences Revenue in Genome Editing and Genome Engineering Business (2018-2023) & (US$ Million)
Table 111. Tecan Life Sciences Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Genome Editing and Genome Engineering Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Genome Editing and Genome Engineering Market Share by Type: 2022 VS 2033
Figure 3. CRISPR Features
Figure 4. TALEN Features
Figure 5. ZFN Features
Figure 6. Global Genome Editing and Genome Engineering Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Genome Editing and Genome Engineering Market Share by Application: 2022 VS 2033
Figure 8. Cell Line Engineering Case Studies
Figure 9. Animal Genetic Engineering Case Studies
Figure 10. Plant Genetic Engineering Case Studies
Figure 11. Others Case Studies
Figure 12. Genome Editing and Genome Engineering Report Years Considered
Figure 13. Global Genome Editing and Genome Engineering Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Genome Editing and Genome Engineering Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Genome Editing and Genome Engineering Market Share by Region: 2022 VS 2033
Figure 16. Global Genome Editing and Genome Engineering Market Share by Players in 2022
Figure 17. Global Top Genome Editing and Genome Engineering Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genome Editing and Genome Engineering as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Genome Editing and Genome Engineering Revenue in 2022
Figure 19. North America Genome Editing and Genome Engineering Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Genome Editing and Genome Engineering Market Share by Country (2018-2033)
Figure 21. United States Genome Editing and Genome Engineering Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Genome Editing and Genome Engineering Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Genome Editing and Genome Engineering Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Genome Editing and Genome Engineering Market Share by Country (2018-2033)
Figure 25. Germany Genome Editing and Genome Engineering Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France Genome Editing and Genome Engineering Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. Genome Editing and Genome Engineering Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy Genome Editing and Genome Engineering Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia Genome Editing and Genome Engineering Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries Genome Editing and Genome Engineering Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Genome Editing and Genome Engineering Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Genome Editing and Genome Engineering Market Share by Region (2018-2033)
Figure 33. China Genome Editing and Genome Engineering Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan Genome Editing and Genome Engineering Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea Genome Editing and Genome Engineering Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia Genome Editing and Genome Engineering Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India Genome Editing and Genome Engineering Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia Genome Editing and Genome Engineering Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Genome Editing and Genome Engineering Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Genome Editing and Genome Engineering Market Share by Country (2018-2033)
Figure 41. Mexico Genome Editing and Genome Engineering Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil Genome Editing and Genome Engineering Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Genome Editing and Genome Engineering Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Genome Editing and Genome Engineering Market Share by Country (2018-2033)
Figure 45. Turkey Genome Editing and Genome Engineering Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia Genome Editing and Genome Engineering Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Thermo Fisher Scientific Revenue Growth Rate in Genome Editing and Genome Engineering Business (2018-2023)
Figure 48. Merck Revenue Growth Rate in Genome Editing and Genome Engineering Business (2018-2023)
Figure 49. Horizon Discovery Revenue Growth Rate in Genome Editing and Genome Engineering Business (2018-2023)
Figure 50. Genscript Revenue Growth Rate in Genome Editing and Genome Engineering Business (2018-2023)
Figure 51. Sangamo Biosciences Revenue Growth Rate in Genome Editing and Genome Engineering Business (2018-2023)
Figure 52. Integrated DNA Technologies Revenue Growth Rate in Genome Editing and Genome Engineering Business (2018-2023)
Figure 53. Lonza Revenue Growth Rate in Genome Editing and Genome Engineering Business (2018-2023)
Figure 54. New England Biolabs Revenue Growth Rate in Genome Editing and Genome Engineering Business (2018-2023)
Figure 55. Origene Technologies Revenue Growth Rate in Genome Editing and Genome Engineering Business (2018-2023)
Figure 56. Transposagen Biopharmaceuticals Revenue Growth Rate in Genome Editing and Genome Engineering Business (2018-2023)
Figure 57. Editas Medicine Revenue Growth Rate in Genome Editing and Genome Engineering Business (2018-2023)
Figure 58. Crispr Therapeutics Revenue Growth Rate in Genome Editing and Genome Engineering Business (2018-2023)
Figure 59. Tecan Life Sciences Revenue Growth Rate in Genome Editing and Genome Engineering Business (2018-2023)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed